Celcuity Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 69.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.39B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
Details
| Name | Celcuity Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 155 |
| Founded | 2011 |
| Ipo Date | 2017-09-20 |
| Ceo | Brian Sullivan |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US15102K1007 |
| Cusip | 15102K100 |
| Cik | 0001603454 |
| Sic | 8071 |
Key executives
| Name | Title |
|---|---|
| Brian F. Sullivan | Co-Founder, Chairman and Chief Executive Officer |
| Dr. Lance G. Laing Ph.D. | Co-Founder, Chief Science Officer, Vice President, Secretary and Director |
| Vicky Hahne CPA | Chief Financial Officer |
| Jodi Sievers | Head of Investor Relations and Corporate Communications |
| Brent Eilefson J.D. | General Counsel and Chief Compliance Officer |
| Sheri Smith | Acting Head of Clinical Operations |
| Igor Gorbatchevsky M.D. | Chief Medical Officer |
| Eldon C. Mayer III, M.B.A. | Chief Commercial Officer |
| Byron Robinson J.D., Ph.D. | Chief Strategy Officer |
Contact
| Address | 2800 Campus Drive, Suite 140, Minneapolis, Minnesota 55441, United States |
| Phone | (763) 392-0123 |
| Website | https://www.celcuity.com |